(16648124), S. C., (16648127), C. C., (16648130), P. M., (15306139), D. D., (16648133), N. S., (14954757), E. d. S., . . . (14126577), T. S. (2025). Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways.
芝加哥风格引文(16648124), Subhamoy Chakraborty, Charles Coleman (16648127), Parvathy Manoj (16648130), Deniz Demircioglu (15306139), Nisargbhai Shah (16648133), Elisa de Stanchina (14954757), Charles M. Rudin (11572933), Dan Hasson (15306151), 与 Triparna Sen (14126577). Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways. 2025.
MLA引文(16648124), Subhamoy Chakraborty, et al. Figure S2 from <i>De Novo</i> and Histologically Transformed Small-Cell Lung Cancer Is Sensitive to Lurbinectedin Treatment Through the Modulation of EMT and NOTCH Signaling Pathways. 2025.